A PYMNTS Company

EU: Zimmer wins EU approval for $13.4 billion Biomet acquisition

By  |  March 30, 2015

U.S. medical device maker Zimmer gained European Union regulatory approval on Monday for its proposed $13.4 billion purchase of rival Biomet after agreeing to divest three businesses in Europe to allay competition concerns.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Zimmer, set to become the No. 2 player in the $45 billion global orthopedics market following the deal, will sell its knee implant unit and Biomet’s elbow implant unit in Europe, as well as BioThe divestments include pipeline projects, intellectual property rights, licenses and customer contracts.

    The European Commission said the businesses will be sold to one or several rivals.

     

    Full Content: The Wall Street Journal

     

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.